Larvol Delta - An-Exploratory-Clinical-Study-of-SCAR02-Targeting-BCMA-and-CD19-for-the-Treatment-of-Refractory-Autoimmune-Diseases

SCAR02 - Siweikang Pharma, Anhui Provincial Hospital

cyclophosphamide - Generic mfg.

http://clinicaltrials.gov/ct2/show/NCT06503224

Jul 16, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next